Evidence map›Paper›PMID 42207948›Full record

ArticleJournal of virology2026

Endocytic motif on HIV-1 Env regulates cleavage status and antibody neutralization of cell-free and cell-to-cell infection.

Dania M Figueroa Acosta, Tony R Valencia, Hongru Li, Benjamin K Chen

Abstract read
In one paragraph

Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dania M Figueroa AcostaDivision of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.ORCID 0000-0003-0245-7832
Tony R ValenciaDivision of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Hongru LiDivision of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Benjamin K ChenDivision of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.ORCID 0000-0002-5404-1997

Funding

Single cell transcriptomics of HIV persistence and latencyR01AI162223 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CHEN, BENJAMIN K · 2021 to 2025
$3.3M
HIV immune evasion and escape through T cell virological synapsesR37AI148064 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BENJAMIN K CHEN · 2022 to 2026
$3.1M
Quantifying bNAb neutralization of the HIV latent reservoirR61AI176585 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CHEN, BENJAMIN K · 2023 to 2025
$1.3M
National Institute of Allergy and Infectious Diseases AI148064National Institute of Allergy and Infectious Diseases AI162223, AI148064-S1National Institute of Allergy and Infectious Diseases AI162223-S1NIAID NIH HHS R01 AI162223NIAID NIH HHS R37 AI148064NIAID NIH HHS R61 AI176585
6 · The paper itself

Abstract

Endocytic recycling regulates the abundance of human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) on the cell surface, where Env comprises both cleaved and uncleaved forms. In contrast, released virions are enriched for cleaved Env. Because cell-free infection depends on virion-associated Env, and cell-to-cell infection is initiated by cell-surface Env, we examined whether Env endocytosis alters the balance of cleaved and uncleaved Env available for antibody recognition and thereby influences neutralization sensitivity in each transmission mode. To address this, we engineered an endocytic-deficient (ASPI-Env) and a cleavage-deficient (SEKS-Env) Env in a transmitted/founder clade B background. We compared them with wild-type Env using surface immunoprecipitation, ratiometric antibody binding, and neutralization assays. Disruption of the endocytic motif increased surface exposure of uncleaved Env and shifted the antigenic profile toward an uncleaved Env phenotype. Infection by cell-free virus particles carrying ASPI-Env showed increased sensitivity to antibodies that preferentially recognize uncleaved or open Env conformations (b12 and 17b), while its sensitivity to the cleaved Env-preferring epitope recognized by PGT151 was similar to wild type. In contrast, cell-to-cell infection showed minimal changes in neutralization sensitivity across the antibody panel, except for b12, which exhibited increased potency and greater inhibition of cell-to-cell HIV-1 transfer. Additionally, uncleaved SEKS-Env functioned in a CD4-dependent virion transfer assay, indicating a previously unappreciated ability to initiate cell-to-cell viral transfer. Together, these findings suggest that Env endocytosis shapes the heterogeneous pool of Env engaged in infection, thereby influencing antibody engagement, with important implications for HIV-1 vaccine strategies. IMPORTANCE: Env endocytosis shapes the antigenic landscape of HIV-1 by influencing the cleavage state of Env on both cells and virions. Env lacking a dominant internalization signal displays more uncleaved Env at the cell surface, thereby enhancing recognition by antibodies that preferentially target open or uncleaved conformations. Notably, cleavage-deficient Env can support CD4-dependent, cell-to-cell viral transfer, indicating that uncleaved cell surface Env can participate in early events of cell‑to‑cell infection. Together, these results suggest that Env sorting pathways influence cleavage-associated antigenicity and underscore the importance of considering both cleaved and uncleaved Env conformations in vaccine and cure strategies.

Indexed as

Antibodies, NeutralizingEndocytosisenv Gene Products, Human Immunodeficiency VirusHIV-1HIV AntibodiesHIV InfectionsCell LineHEK293 CellsHumansNeutralization TestsVirionVirus InternalizationAntibodies, Neutralizingenv Gene Products, Human Immunodeficiency VirusHIV AntibodiesbNAbscell-free infectioncell-to-cell infectionconformational statesendocytic recyclingHIV-1 envelope (Env)human immunodeficiency virus subtype 1 (HIV-1)neutralization

Identifiers

PMID42207948
PMCPMC13289170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.